You can Subscribe to our RSS FEED:
which delivers brain tumor news and additions
to the website via RSS.
Click HERE for details on RSS.
Displaying items 26 to 50 of about 5170
Amazon Smile Fundraiser! Action Required!
Musella Foundation awards two brain tumor research grants!
First Glioblastoma Patient Dosed in Phase 2 Trial Testing PVSRIPO Plus Keytruda
Very Low Mutation Burden Is a Feature of Inflamed Recurrent Glioblastomas Responsive to Cancer Immunotherapy
Mebendazole and temozolomide in patients with newly diagnosed high-grade gliomas: results of a phase 1 clinical trial
Imvax Announces Publication of Phase 1b Clinical Trial of IGV-001 for Patients with Newly Diagnosed Glioblastoma in Clinical Cancer Research
Learn More About GammaTile® Therapy, Surgically Targeted Radiation Therapy For Brain Tumors, At Patient Education Event On Thursday, February 4
NEW MAGNETIC RESONANCE IMAGING (MRI) TECHNIQUE UNCOVERS PATHOPHYSIOLOGICAL PROCESS TO HELP EARLY DETECTION OF RECURRENT GLIOBLASTOMA
Targepeutics Receives Orphan Drug Designation for Lead Drug Targeting Malignant Glioma
Outcomes and Patterns of Care in Elderly Glioblastoma Multiforme Patients: A Population-Based Study of the National Cancer Database
The Role of Temozolomide in Patients With Newly Diagnosed Wild-Type IDH, Unmethylated MGMTp Glioblastoma During the COVID-19 Pandemic
Brain Cancer Advocate Al Musella Joins Childhood Cancer Foundation Board of Directors
Body mass index as an independent prognostic factor in glioblastoma
Mitochondria in Overdrive Linked to Glioblastomas
There Is New Hope for Those Fighting the Same Cancer That Took John McCain & Ted Kennedy; Using Polio & Immunotherapy to Fight Brain Tumors
Toxoplasma gondii infection and the risk of adult gliomain two prospective studies
U of M begins Phase I of first-in-human clinical trial for glioblastoma
Chimerix places its bets on Oncoceutics` dopamine antagonist for rare brain cancer in quest to salvage its image
Kintara Therapeutics and Kazia Therapeutics drugs to enter glioblastoma trial
Daiichi Sankyo Submits Application for Oncolytic Virus Teserpaturev (G47?) for Treatment of Patients with Malignant Glioma in Japan
Leptomeningeal Spread in Glioblastoma: Diagnostic and Therapeutic Challenges
Ovarian tissue cryopreservation and transplantation in patients with central nervous system tumours
Musella Foundation awards three brain tumor research grants and reopens the brain tumor treatments copayment assistance program!
Musella Foundation Copay Assistance Program is now open!
Game changing brain surgery treatment gets Health Canada approval
Brain Tumor News Blast
Enter your email address to subscribe!
Copyright © 1993 - 2021 Musella Foundation- All Rights Reserved.
Website by LcsProductionDesign.com